Zelira Therapeutics Launches HOPE Autism Products In Australia

Medical cannabis company Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF) has just announced the launch of its HOPE line of products for autism in Australia. 

The HOPE range of products will be distributed nationally via Health House Holdings. They will be available to Australian patients through a prescription issued via the country’s Therapeutic Goods Administration (TGA) Special Access Scheme (SAS).

The SAS allows authorized doctors to prescribe therapeutic goods that are otherwise unapproved for general access in Australia’s health care system. In most …

Full story available on Benzinga.com

More Zelira Therapeutics Launches HOPE Autism Products In Australia